THC Temperature Responses Changed From Cooling to Warming During Repeated Dosing in Rats

A 1978 rat study found that repeated THC eliminated an initial cooling response and later produced warming. Behavioral adaptation, body-weight gain and brain monoamine measurements did not all follow the same course.

The regimen used daily intravenous exposure

Rats with indwelling catheters received THC for up to ten days. Temperature was recorded over time on selected days, while separate groups supplied brain tissue for monoamine analysis. Tissue measurements therefore were not repeated within the same individual animals.

Adaptation did not mean every outcome normalized

Tolerance to hypothermia appeared by day three, with hyperthermia on later days. Tolerance was described for excitatory and depressant behaviors, but reduced body-weight gain persisted over the study. Temperature returning past baseline in the opposite direction is different from simply losing a drug effect.

Monoamine content was not a direct release measurement

Noradrenaline and dopamine levels were not markedly changed. Serotonin and its metabolite 5-HIAA showed time-dependent differences. These whole-tissue content measures cannot by themselves identify release, receptor activity or the mechanism producing the temperature change. The authors proposed relationships rather than demonstrating a complete causal chain.

The experiment shows why repeated-exposure effects require a time course and multiple endpoints. It does not establish a human temperature-risk prediction or demonstrate that tolerance eliminates nutritional or physiological effects. Dose route, sampling method and the distinction between reversal and recovery remain important.

Related: interpreting cannabis tolerance claims.

Research cited

Taylor DA; Fennessy MR. Relationship between body temperature and brain monoamines during the development of tolerance to delat9-tetrahydrocannabinol in the rat. Psychopharmacology (1978). doi:10.1007/BF00432850. Findings discussed from the study abstract.

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

A 2026 Cannabis Review Explains Why Potency, Placebo Response and Sedation Need Separate Measures

A 2026 narrative review argues that product potency is not the same as delivered THC dose and that placebo responses remain important among experienced users. Its laboratory framework also distinguishes reduced drug reinforcement from nonspecific sedation. Users can change how they inhale The review notes that participants alter inhalation patterns…

Spread the love

Read Article: A 2026 Cannabis Review Explains Why Potency, Placebo Response and Sedation Need Separate Measures

THC Antinociception Persisted Without the Same Dynorphin Signal in Tolerant Rats

A 1999 rat study found that tolerance weakened THC-related modulation of spinal dynorphin, while antinociception could still occur without the same elevated dynorphin measure. The role of a downstream signal changed with dose and adaptive state. The experiment examined spinal responses The work followed earlier findings linking acute intrathecal THC…

Spread the love

Read Article: THC Antinociception Persisted Without the Same Dynorphin Signal in Tolerant Rats

A Passiflora-Derived Fraction Reduced THC Withdrawal Signs in a Mouse Model

A 2002 mouse experiment reported fewer antagonist-precipitated withdrawal signs with a Passiflora-derived benzoflavone fraction. The finding concerns a defined experimental preparation and animal model, not a demonstrated treatment for cannabis-use disorder in people. Concurrent and acute interventions were tested Mice received repeated oral THC with or without the fraction. A…

Spread the love

Read Article: A Passiflora-Derived Fraction Reduced THC Withdrawal Signs in a Mouse Model

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us